S913 phosphorylation of Ulk1 protects the heart from aging through inhibition of cardiac senescence
Cardiovascular Research · 2025
DOI: 10.1093/cvr/cvaf129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2025. Verfasst von Peiyong Zhai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, Rutgers-New Jersey Medical School, 185 South Orange Ave, Newark…. Hauptthemen laut MEDLINE: Autophagy-Related Protein-1 Homolog, Myocytes, Cardiac, Cellular Senescence, Aging. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Heart Association, Fondation Leducq, NHLBI NIH HHS.
Abstract (Originalsprache)
Aims
We have previously shown that prevention of GSK-3β inactivation with GSK-3β (S9A) stimulates autophagy through phosphorylation of Ulk1 at Ser913. In the current study, we investigated whether cardiac aging is accelerated in Ulk1S913A knock-in mice and whether cardiomyocyte senescence plays an important role in the development of aging cardiomyopathy in these mice. Methods and results In systemic heterozygous Ulk1S913A knock-in mice (shS913A), cardiac dysfunction (evidenced by lower ejection fraction and fractional shortening, lower dP/dtmaximum, higher end-diastolic pressure, and higher dP/dtminimum) and fibrosis, along with increased cardiomyocyte senescence (increased P16, P21, IL6, γH2AX, and P53), were observed at 18 months old. RNA-seq analysis showed that numerous genes are differentially expressed in shS913A and littermate wild type (WT) hearts, including those involved in glucose metabolism, cardiac fibrosis, and cellular senescence. The glycolytic activity was higher in adult mouse cardiomyocytes isolated from shS913A than in those from littermate WT mice. In cultured neonatal rat ventricular cardiomyocytes, overexpression of Ulk1S912A induced cellular senescence. Heterozygous cardiac-specific Ulk1S913A knock-in mice (chS913A) developed cardiac dysfunction, hypertrophy, fibrosis, and senescence at 7 months old. ABT-263 treatment (senolysis) attenuated the cardiac dysfunction, hypertrophy, and fibrosis while decreasing the number of γH2AX-positive cardiomyocytes.
Conclusion
The chS913A mice exhibit premature cardiac aging, which is mediated through stimulation of cardiomyocyte senescence. The results support the role of the GSK-3β-Ulk1-autophagy pathway in the heart during aging. Thus, these mice could be useful in studying cardiac aging and senescence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology and Molecular Medicine, Cardiovascular Research Institute, Rutgers-New Jersey Medical School, 185 South Orange Ave, Newark, NJ 07103, USA.
ORCID-Profile: Peiyong Zhai, Eun-Ah Sung, Yasuki Nakada, Junichi Sadoshima
Förderung
- American Heart Association
- Fondation Leducq
- NHLBI NIH HHS
- U.S. Public Health Service
Zitieren
APA
Zhai, P., Sung, E. A., Takayama, K., Ikeda, S., Matsushita, M., Nakada, Y., Tian, Y., & Sadoshima, J. (2025). S913 phosphorylation of Ulk1 protects the heart from aging through inhibition of cardiac senescence. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf129
Vancouver
Zhai P, Sung EA, Takayama K, Ikeda S, Matsushita M, Nakada Y, et al. S913 phosphorylation of Ulk1 protects the heart from aging through inhibition of cardiac senescence. Cardiovascular Research. 2025. doi:10.1093/cvr/cvaf129
BibTeX
@article{Zhai2025,
author = {Zhai, Peiyong and Sung, Eun-Ah and Takayama, Koichiro and Ikeda, Soichiro and Matsushita, Masato and Nakada, Yasuki and Tian, Yimin and Sadoshima, Junichi},
title = {S913 phosphorylation of Ulk1 protects the heart from aging through inhibition of cardiac senescence},
journal = {Cardiovascular Research},
year = {2025},
doi = {10.1093/cvr/cvaf129}
}
EUVIMED